Citius Oncology Inc (CTOR)

1.20 +0.17 (+16.98%) USD  |  NASDAQ  |  Nov 05, 16:00
1.18 -0.02 (-1.67%) After-Hours: 19:06
More

Citius Oncology EBIT Margin (TTM)

EBIT Margin (TTM) Chart

View EBIT Margin (TTM) for CTOR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EBIT Margin (TTM) Data

View and export this data back to . Upgrade now.
Date Value

EBIT Margin Definition

An EBIT Margin is the operating earnings over operating sales. This margin allows investors to understand true business costs of running a company, because parts of a company's property, plant, and equipment will eventually need to be replaced as they get used, broken down, decayed, etc.

Read full definition.

EBIT Margin (TTM) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

EBIT Margin (TTM) Benchmarks

Citius Pharmaceuticals Inc --
NovaBay Pharmaceuticals Inc Upgrade
Palatin Technologies Inc --
iBio Inc --
Theriva Biologics Inc --